Licealiz

Quick links to important sections

Licealiz

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Licealiz

What is Licealiz? Identity and Classification

Property Description
Active Ingredient Pyrethrin I (and Pyrethrins)
Form Topical Solution, Shampoo
Pharmacological Class Pediculicide, Ectoparasiticide
Common Use Elimination of Lice Infestation (Pediculosis)
Origin Naturally occurring (Pyrethrum extract)

What is Licealiz and What Type of Medicine is It?

Licealiz is an ectoparasiticide and a pediculicide medication specifically designed to eliminate external parasites, such as lice, from the body. It is typically marketed as a specific brand and is an Over-the-Counter (OTC) preparation intended for external use only. The product is clinically recognized for its use as a primary agent in controlling pediculosis (lice infestations).

The medicine's active core is Pyrethrin I, classifying it within the Pyrethrin pharmacological group. The primary role is to treat the infestation directly, a common use being the rapid treatment of head lice. Its classification as an ectoparasiticide underscores its specialized purpose, which is to provide a highly targeted chemical means for controlling this specific type of parasitic burden.


Composition, Origin, and Topical Form

The active ingredient in Licealiz is Pyrethrin I, a compound distinguished by its natural origin as it is derived from the Pyrethrum extract of the Chrysanthemum cinerariifolium flower. The brand is characteristically available in a topical dosage form, primarily as a shampoo or solution intended for application to the hair and scalp.

This composition places the Pyrethrins in a distinct category from synthetic pyrethroids. Pyrethrins often require a synergist, such as Piperonyl Butoxide, to enhance their overall insecticidal effectiveness. The use of a topical form facilitates the external route of administration, which delivers the therapeutic agents directly to the site of the infestation where the lice and nits reside.


What is the General Purpose of Licealiz?

The general purpose of Licealiz is to achieve the elimination of the parasitic burden by rapidly killing adult lice through targeted neurotoxic action. This action is the fundamental benefit that the medication provides to individuals suffering from a lice infestation.

The Pyrethrin I acts quickly as a nerve agent, causing paralysis (often called the "knockdown" effect) and the subsequent demise of the organism. This primary insecticidal activity efficiently stops the life cycle of the infestation. Consequently, the medicine is used to provide prompt and direct relief from the discomfort and contagiousness associated with active pediculosis.

Regulatory References

  1. NIH DailyMed: Pyrethrins

What side effects are possible with Licealiz?

Officially Documented Adverse Reactions and Safety Profile

The safety profile for Licealiz, which contains Pyrethrins, is structured by authoritative regulatory documents, prioritizing localized cutaneous reactions due to its external, topical route of administration. The documented adverse reactions primarily fall under Skin and Subcutaneous Tissue Disorders.


Frequency-Classified Adverse Reactions

The most frequently reported events are classified as Common/Expected and are generally transient, occurring at the application site:

  • Dermatological Events: A sensation of burning or stinging, local pruritus (itching), and erythema (redness) are commonly listed in regulatory data. Less commonly reported effects include temporary tingling or numbness.
  • Systemic Events: Headache and dizziness are reported, along with rare systemic effects like nausea or vomiting associated with accidental ingestion or high exposure.

Serious Safety Considerations and Restrictions

The most critical constraint in the official safety profile is the risk of Severe Hypersensitivity Reactions. The product is formally contraindicated in patients with known hypersensitivity to any of its components or to Pyrethrins. Specific regulatory notes indicate that individuals with an existing ragweed allergy are at risk for a severe allergic response, which may manifest as breathing difficulty or an asthmatic attack.

Safety notes also constrain use to external application only, with strict avoidance of the eyes and mucous membranes to prevent severe local irritation. Furthermore, pruritus may persist for a period after treatment, a pattern officially noted to be rarely indicative of treatment failure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents define the overdose profile of Pyrethrins and Piperonyl Butoxide primarily based on the outcomes of accidental exposure, particularly oral ingestion.

Documented Manifestations and Severe Outcomes

Accidental ingestion of the topical solution is associated with the most severe systemic effects. Documented clinical manifestations of overdose include significant gastrointestinal distress, specifically nausea, vomiting, and abdominal pain. More severe outcomes involve the central nervous system, where signs may escalate to seizures and coma. Respiratory distress is also a serious documented concern, including the risk of respiratory arrest. Localized overdose from excessive dermal exposure may present as persistent skin irritation, burning, or redness (erythema). Neurological signs such as paresthesia (tingling or numbness) and muscle tremors are also noted in the regulatory literature.

Emergency Actions Required

Regulatory authorities mandate immediate medical attention for specific overdose scenarios. If the product is swallowed, an individual must contact a Poison Control Center right away or seek emergency medical help. Furthermore, the label requires stopping use and seeking a doctor immediately if symptoms such as breathing difficulty or an allergic reaction occur, particularly in individuals with a known sensitivity (e.g., to ragweed). Treatment is limited to symptomatic and supportive measures, as no specific antidote is known. Hospital monitoring and decontamination procedures, such as flushing exposed areas, are often required.

Therapeutic Uses of Licealiz

Managing Active Head Lice and Nits (Pediculosis)

This medication is primarily used in situations involving the symptomatic discomfort of an active head lice infestation, which includes the presence of live adult lice (kuto) and their eggs (nits or lisa). It is commonly used for managing conditions associated with acute or disruptive episodes of pediculosis, specifically to address the scalp itching, irritation, and the sensation of movement that are the main symptoms. Medications in this category are applied in addressing the presence of the parasites, which supports the therapeutic management of the infestation. This approach offers symptomatic relief that helps patients cope more steadily with difficult episodes.


Supporting Management Against Reinfestation and Recurrence

Licealiz is also relevant in contexts marked by increased discomfort or tension, such as following symptomatic management. It is applied in contexts where additional symptomatic support is needed to help manage the cycle of reinfestation, particularly in household or communal settings, and it may assist with maintaining functional stability when symptoms of potential reinfestation are a concern, which contributes to easing the overall symptom load.

“The product may be part of symptomatic management, applied in areas where additional support for easing discomfort is needed.”

The medication is used in areas where short-term symptom management is appropriate for both active head lice infestation and managing the risk of reinfestation.

Quick Fact: Relief for Scalp Irritation (The medication is used to help address symptoms related to inflammatory or irritative states of the scalp.)

Regulatory References

  1. NIH MedlinePlus overview on Permethrin Topical

Eligibility and Restrictions for Use

Eligibility for Licealiz: Official Regulatory Status

Eligibility for Licealiz is strictly defined by regulatory documents, focusing on population characteristics and pre-existing conditions.


Approved Populations

Licealiz is approved for use in adults and children 2 years of age and older. The medicine is generally acceptable and permitted for use by pregnant individuals and nursing mothers; in fact, some health authorities cite it as a drug of choice for treatment in these populations. Individuals with hepatic impairment are permitted standard use, as no dosage adjustments are officially recommended.


Contraindications and Restrictions

Licealiz is contraindicated in individuals with a known hypersensitivity or allergy to pyrethrins, piperonyl butoxide, or any component of the formulation. Due to the botanical origin, it is also contraindicated for patients with allergies to ragweed or chrysanthemum plants. Use is not recommended for children under 2 years of age. Additionally, the product must not be used on areas of the skin that are acutely inflamed, raw, or weeping. Patients with a history of asthma should only use the product with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Licealiz is defined by the minimal risk of clinically significant systemic interactions with other medicines, foods, or supplements. This outcome is attributed directly to the product's topical route of administration as a solution or shampoo, which results in the low systemic absorption of the active ingredients, Pyrethrins and Piperonyl Butoxide.

Systemic Drug-Drug Interactions

Government health authorities confirm that no known significant systemic drug-drug interactions are formally documented for this topical medication. The minimal concentration of active ingredients reaching the bloodstream effectively limits the potential for altering the clearance or plasma exposure of other systemically administered medicines.

  • Contraindicated Combinations: No specific medicinal products are listed in official regulatory prescribing information as being formally contraindicated for co-administration based on a systemic interaction risk.
  • Metabolic and Transporter Interactions: No significant interactions mediated by human metabolic enzymes (e.g., CYP450) or drug transporters are formally documented.

Administration Constraints and Consumption Products

Due to the lack of significant systemic interaction findings in regulatory data:

  • Timing Separation: Regulatory labels do not impose mandatory timing rules requiring separation of Licealiz application from the administration of other medicines.
  • Food and Supplements: No specific interactions with food, alcohol, or herbal products are formally documented in official prescribing information.
  • Population Cautions: Interaction severity cautions specific to populations, such as those with hepatic or renal impairment, are not noted in the official regulatory profile.

Mechanism of Action

Licealiz is a synthetic pyrethroid compound which acts as a neurotoxin. The compound selectively targets the voltage-sensitive sodium channels in the excitable membranes of the arthropod nervous system. Licealiz is a sodium channel modulator; it binds to and modifies the gating mechanism of these channels. This interaction prevents the channels from properly inactivating, leading to a prolonged state of channel opening and a persistent influx of sodium ions into the nerve cell. The sustained sodium influx causes a continuous depolarization of the postsynaptic membrane. This results in repetitive neuronal firing and hyperexcitation of the nerve fiber. Downstream, this continuous nerve impulse transmission causes cellular hyperactivity and eventual disruption of central and peripheral nervous system function. The systemic physiological consequence is a loss of coordinated motor function and subsequent physiological collapse.

Dosage and Administration Information

How to Use Licealiz: Official Administration Guidelines

Licealiz, a topical formulation containing Pyrethrins and Piperonyl Butoxide, is administered solely via the topical route for the management of lice infestations. The use is strictly for external application and is not dependent on systemic factors such as meal timing.


Administration Scope

Instruction Entity Regulatory Standard
Route of administration: Topical (External use only).
Dosing schedule: Apply a sufficient amount to completely saturate all dry hair and the entire scalp; typical application quantities range from 30 to 120 mL (1–4 fl oz), depending on hair length.
Age-group rules: Approved for adults and children 2 years of age and older. Use in children under 2 years requires consulting a healthcare professional.

Treatment Frequency and Procedural Structure

The standard protocol for the use of this medicine involves a short-term, two-step regimen. The initial application serves to begin the treatment course, and a second application is mandated to eliminate any newly hatched lice that may emerge from nits after the first use.

Classification Description
Frequency pattern: Two applications administered over a course of 7 to 10 days.
Special procedural conditions: Must remain on the treated area for a precise duration of 10 minutes before being thoroughly rinsed with warm water.
Required post-treatment step: Following rinsing, the official procedure includes the mandatory use of a fine-toothed comb (nit comb) to physically remove dead parasites and nits from the hair.

This structured administration, including the precise contact time and the required second application, constitutes the full, label-mandated protocol for proper product use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Licealiz (Pyrethrins)

The information below summarizes the available scientific research and clinical trial structure for products containing Pyrethrins, the active ingredient in Licealiz. This overview is purely descriptive and does not contain clinical guidance or recommendations.


Evidence for Use in Active Head Lice Infestation (Pediculosis Capitis)

Research on Pyrethrins was studied for its observed clearance rates in people with an active lice infestation. The evidence base for Pyrethrins largely consists of Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that combine and analyze data from multiple trials.

Studies monitored outcomes related to physical discomfort by defining and measuring the clearance rate, which describes the percentage of participants who showed no signs of live lice or viable eggs at the end of the study period. Findings describe patterns observed in the studies related to the overall clearance. However, findings were mixed across some trials, and this variability may be associated with differences in the specific product used or the local characteristics of the lice population.

Research also describes how outcomes related to lice eggs (nits) were evaluated. Evidence suggests that two applications of the medication was observed in some studies to observe the outcomes related to newly hatched lice after initial treatment. This approach is related to the finding that the medication was observed to have limitations related to nit viability itself, reflecting the common study design of following up the initial application with a second one.


Study Design and Outcomes Measured

Investigators structured studies to measure specific outcomes related to achieving clearance from the parasitic burden. The research focused on the measurement of live lice counts and the assessment of nit viability on the scalp. Outcomes linked to inflammatory or irritative states, such as changes in reported scalp itching, were also monitored. These outcomes reflect daily functioning or activity level outcomes that patients report.

Pyrethrins was evaluated in trials that used different formulations to explore short-term symptom changes. These studies reported how symptoms evolved in the observed populations during the study period, and the measured outcomes were compared.


Areas of Research Uncertainty and Study Limitations

One key limitation noted in the scientific literature is the documented variability in study findings. This evidence quality varies across studies because of differences in the specific formulations tested and variations in the application protocols. Furthermore, research describes patterns related to varying levels of lice resistance across different geographic areas, which can impact the consistency of outcomes observed in the trials.

Researchers acknowledge that subgroup findings are uncertain and that comparative evidence is lacking for some of the newer treatment options. These limitations mean that while studies help show what has been observed so far, researchers note that continued study is needed to address these areas of uncertainty.

Key Studies & References NIH DailyMed: Pyrethrins and Piperonyl Butoxide Topical Solution - Drug Label

Frequently Asked Questions (FAQ)

Common questions about Licealiz (FAQ)


Q: What should I do if the itching (pruritus) continues for a few days after I've used Licealiz?

According to official product information, itching or irritation of the scalp may occasionally persist even after successful treatment. While this pattern is expected, it is generally noted that observation of the area may be helpful. Official regulatory sources note that if irritation or infection persists, consulting a doctor or healthcare professional is recommended.


Q: What is the recommended amount of product (dosing) to use for someone with very long hair?

The volume of product to use depends on the length and thickness of the hair, as the entire scalp and hair must be fully saturated. For individuals with very long hair, the volume may be toward the upper end of the suggested range. Official regulatory directions state that the total amount used over the two required applications may range up to 4 to 6 fluid ounces to ensure full coverage.


Q: Does Licealiz kill the nits (eggs) as well as the adult lice, or just the adults?

Licealiz is a pediculicide, which indicates its purpose is to treat the infestation by killing adult lice. Official information acknowledges that the medication may have limitations regarding the viability of lice eggs (nits). This is consistent with the standard protocol which includes a second application 7 to 10 days later to kill any newly hatched lice. Additionally, regulatory protocols require using a fine-toothed comb to physically remove all dead lice and nits after rinsing the product.


Q: Where can I purchase Licealiz?

The active ingredients in Licealiz (Pyrethrins and Piperonyl Butoxide) are regulated under an Over-the-Counter (OTC) Drug Monograph by government health authorities. This regulatory status means the product is approved to be sold directly to consumers without the need for a prescription. This classification typically allows the product to be found at drugstores, pharmacies, and grocery stores.

How should Licealiz be stored and disposed of?

How to Store and Dispose of Licealiz?

The storage and disposal of this product (Pyrethrins/Piperonyl Butoxide) must follow official regulatory requirements to ensure stability and environmental protection.


Official Storage Requirements

Mandatory Storage Temperature: The solution must be stored at Controlled Room Temperature, specifically 20°C to 25°C (68°F to 77°F). It is required to not freeze the product and to avoid excessive heat. Store the container in a location protected from direct light and excess moisture.

Child Safety: The medication must be kept out of reach of children and stored in its closed container.


Disposal Instructions

Environmental Protection: Unused or expired product must not be poured down any drain, sewer system, or water course due to the toxicity of the active ingredients to aquatic life. For disposal of any partly filled quantity, contact a local solid waste agency for specific instructions. Empty containers should be placed in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Licealiz found in:

A-Z Index: